Reporting of serious adverse events during cancer clinical trials to the institutional review board: An evaluation by the research on adverse drug events and reports (RADAR) project
S. M. Belknap*, C. H. Georgopoulos, J. Lagman, S. A. Weitzman, L. Qualkenbush, P. R. Yarnold, B. J. Edwards, J. M. McKoy, S. M. Trifilio, D. P. West
Dive into the research topics of 'Reporting of serious adverse events during cancer clinical trials to the institutional review board: An evaluation by the research on adverse drug events and reports (RADAR) project'. Together they form a unique fingerprint.